Recombinant IL2RA (Daclizumab Biosimilar) anticorps

N° du produit ABIN7487732

Cet anticorps Souris Chimeric détecte spécifiquement IL2RA (Daclizumab Biosimilar) dans FACS et BR. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant IL2RA (Daclizumab Biosimilar) anticorps (ABIN7487732)

Antigène: IL2RA (Daclizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Chimeric

Conjugué: Cet anticorp IL2RA (Daclizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), Blocking Reagent (BR)

Détail du produit anti-IL2RA (Daclizumab Biosimilar) anticorps

Fonction: Anti-IL-2R [Daclizumab], Mouse IgG1, kappa

Specificité: Binds to p55 chain of IL2R on human T cells, Tac antigen, which is expressed on T cells activated by mitogens, soluble antigens, and alloantigens but not on resting T cells, thymocytes, B cells, monocytes, activated B cells, leukemic T cell blasts from patients with acute lymphoblastic leukemia, and long-term T cell lines.

Réactivité croisée: Cynomolgus, Macaque rhésus

Attributs du produit:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Immunogène: Cultured T-cells derived from a patient with Mycosis fungoides.

Isotype: IgG1 kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur IL2RA (Daclizumab Biosimilar)

Antigène: IL2RA (Daclizumab Biosimilar)

Sujet: CD25, Interleukin-2 receptor subunit alpha, IL-2 receptor subunit alpha, IL-2R subunit alpha, IL-2-RA, IL2-RA, TAC antigen, p55

UniProt: P01589